Spruce Biosciences annual meeting results: directors elected, say-on-pay passed, frequency set to every year

SPRUCE BIOSCIENCES, INC.

Annual meeting held May 21, 2026; quorum of 65.86% (903,893 of 1,372,278 shares outstanding).
Class III directors elected: Michael Grey (276,159 for), Camilla V. Simpson (191,284 for), Javier Szwarcberg (293,098 for).
Ratification of BDO USA as auditor for FY 2026 approved: 880,984 for, 16,851 against.
Advisory say-on-pay approved with 187,027 for, 111,274 against, 1,573 abstentions (62.7% approval on votes cast).
Stockholders voted for annual advisory votes on executive compensation; company will hold annual say-on-pay until 2032.

item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-239230
form_type: 8-K
ticker: SPRB
cik: 0001683553
company_name: SPRUCE BIOSCIENCES, INC.
filed_at: 2026-05-26T20:02:57+00:00
discovered_at: 2026-05-26T20:04:01.641365+00:00
generated_at: 2026-05-26T20:04:42.396813+00:00
sec_items: ["5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.25
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-239230
json_url: https://secwatch.observer/filing/0001193125-26-239230.json
markdown_url: https://secwatch.observer/filing/0001193125-26-239230.md
text_url: https://secwatch.observer/filing/0001193125-26-239230.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1683553/000119312526239230/0001193125-26-239230-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1683553/000119312526239230/sprb-20260521.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-239230

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.